6-Iodo-1H-indazole - CAS 261953-36-0
Catalog: |
BB019189 |
Product Name: |
6-Iodo-1H-indazole |
CAS: |
261953-36-0 |
Synonyms: |
6-iodo-1H-indazole; 6-iodo-1H-indazole |
IUPAC Name: | 6-iodo-1H-indazole |
Description: | 6-Iodo-1H-indazole (CAS# 261953-36-0) is an intermediate used to synthesize inhibitors of Chk1. |
Molecular Weight: | 244.03 |
Molecular Formula: | C7H5IN2 |
Canonical SMILES: | C1=CC2=C(C=C1I)NN=C2 |
InChI: | InChI=1S/C7H5IN2/c8-6-2-1-5-4-9-10-7(5)3-6/h1-4H,(H,9,10) |
InChI Key: | RSGAXJZKQDNFEP-UHFFFAOYSA-N |
Boiling Point: | 358.2 °C at 760 mmHg |
Density: | 2.082 g/cm3 |
MDL: | MFCD04114695 |
LogP: | 2.16750 |
GHS Hazard Statement: | H302 (97.56%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021124172-A1 | 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 20191218 |
CN-112209860-A | Preparation method of axitinib intermediate | 20190711 |
WO-2020212253-A1 | Process for preparing axitinib, process for purifying the intermediate 2-((3-iodo-1h-indazol-6-yl)thio)-n-methylbenzamide, process for purifying axitinib via the axitinib hcl salt, solid form of the axitinib hcl salt | 20190418 |
WO-2020207352-A1 | Triazine benzimidazole compounds and medical use thereof | 20190411 |
WO-2020210377-A1 | Heterocyclic compounds and uses thereof | 20190409 |
PMID | Publication Date | Title | Journal |
15736192 | 20050401 | Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: Microemulsions without and with glycolipid as penetration enhancer | Journal of pharmaceutical sciences |
15620295 | 20050104 | Biocompatible lecithin organogels: structure and phase equilibria | Langmuir : the ACS journal of surfaces and colloids |
12429489 | 20021024 | Rheological properties of three component creams containing sorbitan monoesters as surfactants | International journal of pharmaceutics |
Complexity: | 129 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 243.94975 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 243.94975 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Indazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS